Weiliang Xu

PepLib is a leading innovator in the peptide industry, specializing in peptide drug discovery, peptide-drug conjugates (PDCs), radionuclide-drug conjugates (RDCs), peptide-oligonucleotide conjugates (POCs), and other peptide-based therapeutics. We are committed to advancing the field of peptide chemistry through cutting-edge research, state-of-the-art technology, and a collaborative approach. My responsibilities include, but are not limited to: 1. Identifying new business opportunities within the peptide pharmaceutical industry or academia, including partnerships, collaborations, and new client acquisitions. 2. Developing and implementing business development strategies to achieve revenue targets and expand market share. 3. Conducting market research to identify trends, customer needs, and the competitive landscape, using insights to inform business strategies. 4. Building and maintaining strong relationships with existing and potential clients, ensuring high levels of customer satisfaction and repeat business. 5. Working closely with R&D, marketing, and production teams to align business development efforts with company objectives. 6. Preparing proposals, negotiating contracts, and managing the deal closure process. 7. Attending industry conferences, trade shows, and networking events to represent the company and identify new opportunities.

Developing tissue-specific peptides for intracellular drug delivery; Synthesizing, purifying, and analyzing complex peptides; Performing peptide conjugation to different classes of biomolecules including proteins, antibodies and oligonucleotides (siRNA or ASO); Optimizing peptide sequence and structure to improve its bioactivity, serum stability, and half-life in vivo; Participating in active research programs in drug discovery and delivery with pharmaceutical collaborators

Supervisor: Prof. Michael Kay; Carrying out research on total chemical synthesis of protein and phage display; Mainly focusing on developing mirror-image peptide inhibitors to immune checkpoints in immunotherapy research.

The second year of Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) Programme; Carrying out research in protein folding, multi-pair disulfide bonds formation, and protein racemic crystallography

The first year of Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) Programme; Undertaking research in protein total synthesis

Supervisor: Prof. Lei LIU; Carrying out research relating to total chemical synthesis of protein; Mainly focusing on mirror-image protein synthesis for drug discovery and prebiotic research

Graduate Research Scholarship for 4 years, Ph. D thesis title: Application of ammonia borane and metal amidoboranes in organic reduction (Supervisor: Assoc. Prof. Ping CHEN)

GPA: 3.8/4 (Top 8 in grade), University Scholarship for 3 years.